GLP-RTA 10MG

£75.00

A novel triple agonist peptide compound targeting GLP-1, GIP, and GCGR (Glucagon) molecular pathways. Laboratory studies demonstrate complex receptor binding profiles affecting cellular energy mechanisms.

SKU RETA10,Category Peptides

Sequence: Modified GLP-1/GIP/Glucagon triple agonist

Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Molecular Formula: C₂₂₇H₃₅₄N₄₈O₆₉

Molecular Weight:4860g/mol

Multi-receptor binding profile
Advanced stability formulation
>99% purity via HPLC-MS
Validated amino acid sequencing
Precise molecular characterization

Triple agonist molecular mechanism
Documented receptor binding affinity
Multi-pathway cellular signaling activator
Extended half-life modifications
Characterized metabolic properties, activates GIP, GLP-1, and Glucagon Receptors
Advanced molecular stability profile

Independent U.S. laboratory testing via HPLC-MS
GMP-certified manufacturing
Sterile facility production
Third-party testing verification
Certificate of Analysis included

Discover

Products

Menu